Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 2
2006 4
2008 1
2009 1
2014 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Tomita N, Kodama F, Tsuyama N, Sakata S, Takeuchi K, Ishibashi D, Koyama S, Ishii Y, Yamamoto W, Takasaki H, Hagihara M, Kuwabara H, Tanaka M, Hashimoto C, Yamazaki E, Koharazawa H, Fujimaki K, Sakai R, Fujisawa S, Ishigatsubo Y. Tomita N, et al. Among authors: kodama f. Hematol Oncol. 2015 Mar;33(1):9-14. doi: 10.1002/hon.2136. Epub 2014 Feb 11. Hematol Oncol. 2015. PMID: 24519501 Clinical Trial.
Secondary central nervous system lymphoma.
Tomita N, Kodama F, Kanamori H, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: kodama f. Int J Hematol. 2006 Aug;84(2):128-35. doi: 10.1532/IJH97.06091. Int J Hematol. 2006. PMID: 16926134 Review.
Phase II study of CHOP-GR therapy for advanced-stage follicular lymphoma.
Tomita N, Kodama F, Oshima R, Hashimoto C, Koharazawa H, Takemura S, Yamazaki E, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Kanamori H, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: kodama f. Leuk Lymphoma. 2006 Jun;47(6):1041-7. doi: 10.1080/10428190500472784. Leuk Lymphoma. 2006. PMID: 16840195 Clinical Trial.
Outcome of involved-field radiotherapy for stage 1 follicular lymphoma.
Tomita N, Kodama F, Motohashi K, Fujita A, Hyo R, Hashimoto C, Takemura S, Yamazaki E, Taguchi J, Sakai R, Fujisawa S, Kanamori H, Motomura S, Ishigatsubo Y, Takeuchi K. Tomita N, et al. Among authors: kodama f. Int J Hematol. 2006 May;83(4):370-2. doi: 10.1532/IJH97.06041. Int J Hematol. 2006. PMID: 16757443 No abstract available.
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
Motomura S, Hashimoto C, Kodama F, Maruta A, Sakai R, Fujita H, Tomita N, Fujisawa S, Harano H, Koharazawa H, Fujimaki K, Kanamori H, Ishigatsubo Y. Motomura S, et al. Among authors: kodama f. Rinsho Ketsueki. 2005 May;46(5):350-7. Rinsho Ketsueki. 2005. PMID: 16444968 Clinical Trial. Japanese.
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.
Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, Nakano N, Ikeda Y, Sasaki T, Nishioka K, Hara M, Taguchi H, Kimura Y, Kato Y, Asaoku H, Kumagai S, Kodama F, Nakahara H, Hagihara K, Yoshizaki K, Kishimoto T. Nishimoto N, et al. Among authors: kodama f. Blood. 2005 Oct 15;106(8):2627-32. doi: 10.1182/blood-2004-12-4602. Epub 2005 Jul 5. Blood. 2005. PMID: 15998837 Free article. Clinical Trial.
13 results